Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease.
D000995:Antitubercular Agents / Q000627:therapeutic use; D003625:Data Collection; D019992:Databases as Topic; D004352:Drug Resistance, Microbial; D004812:Epidemiologic Methods; D006801:Humans; D007391:International Cooperation; D007753:Laboratories; D008826:Microbial Sensitivity Tests / Q000592:standards; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D010297:Paris; D011159:Population Surveillance; D015995:Prevalence; D011785:Quality Assurance, Health Care; D011786:Quality Control; D012042:Registries; D013048:Specimen Handling; D013183:Sputum / Q000382:microbiology; D018088:Tuberculosis, Multidrug-Resistant / Q000145:classification / Q000453:epidemiology*; D014397:Tuberculosis, Pulmonary / Q000145:classification / Q000453:epidemiology*; D014944:World Health Organization
D000995:Antitubercular Agents